• Overview page

  • Jeff Leyton PhD

  • Endosome escape-Nuclear transport

  • Nuclear active cytotoxin payloads

  • Targeting the 'undruggable'

  • Wolfpack approach

  • Molecular Imaging

  • Team and Location

  • Community impact

  • Education-Protocols

  • Collaborators

  • Blog

  • More

    Use tab to navigate through the menu items.
    • Antibody drug conjugates (8) 8 posts
    • COVID-19 (11) 11 posts

    March 2017 - Latest news with potential next approved ADC Sacituzumab Govitecan - Triple negative br

    Hello! This months posting I hope you will find interesting because its about Sacituzumab Govitecan (SG) and its impressive clinical...
    123
    4